2023 S_T J153912-2 Std_Tal_L4 Final Report_Part1.pdf

PDF 31 MB Posted

Attached to
Maintenance Dredging of Newark Bay, New Jersey, Federal Navigation Project
Solicitation number
W912DS23B0009
Issued by

About this file

Written by GovTribe AI ·

This document provides details on a federal contract opportunity for maintenance dredging of Newark Bay in New Jersey. The solicitation number is W912DS23B0009 and is being issued by the Department of the Army Corps of Engineers Engineering District New York. The opportunity type is a solicitation for maintenance dredging of Newark Bay as part of the Federal Navigation Project. Responses are due based on the standard FAR solicitation response timeline and award will be made thereafter based on evaluation of responses received. The required service is maintenance dredging to keep shipping channels in and around Newark Bay clear for maritime navigation.

View the file

Other files

File Type Posted
Abstract Newark Bay 2023.pdf PDF
W912DS23B0009-00002.pdf PDF
2023 S_T J153912-1 Std_Tal_L4 Final Report_Part9.pdf PDF
2023 S_T J153646-1 Std_Tal_L4 Final Report_Part8.pdf PDF
2023 S_T J153718-1 Std_Tal_L4 Final Report_Part3.pdf PDF
2023 S_T J153718-2 Std_Tal_L4 Final Report.pdf PDF
2023 S_T FINAL - Newark Upland - DO005-w_cond format_Values.xlsx XLSX spreadsheet
2023 S_T NB 180-153646-1_BattelleCorp.xls XLS spreadsheet
2023 S_T J153912-1 Std_Tal_L4 Final Report_Part2.pdf PDF
2023 S_T J153912-1 Std_Tal_L4 Final Report_Part1.pdf PDF
2023 S_T NB 180-153912-1_BattelleCorp.xls XLS spreadsheet
2023 S_T J153718-1 Std_Tal_L4 Final Report_Part5.pdf PDF
2023 S_T J153912-1 Std_Tal_L4 Final Report_Part7.pdf PDF
2023 S_T J153718-1 Std_Tal_L4 Final Report_Part6.pdf PDF
2023 S_T J153256-1 Std_Tal_L4 Final Report_Part5.pdf PDF
2023 S_T J153256-2 Std_Tal_L4 Final Report.pdf PDF
2023 S_T J153718-1 Std_Tal_L4 Final Report_Part4.pdf PDF
2023 S_T NB 180-153912-2_BattelleCorp.xls XLS spreadsheet
2023 S_T J153646-1 Std_Tal_L4 Final Report_Part5.pdf PDF
2023 S_T J153646-1 Std_Tal_L4 Final Report_Part4.pdf PDF
2023 S_T NB DO005 Newark Bay Cover Letter.pdf PDF
2023 S_T J153912-1 Std_Tal_L4 Final Report_Part3.pdf PDF
2023 S_T J153912-1 Std_Tal_L4 Final Report_Part8.pdf PDF
2023 S_T J153718-1 Std_Tal_L4 Final Report_Part1.pdf PDF
2023 S_T J153718-1 Std_Tal_L4 Final Report_Part8.pdf PDF
2023 S_T J153646-1 Std_Tal_L4 Final Report_Part3.pdf PDF
2023 S_T J153912-1 Std_Tal_L4 Final Report_Part5.pdf PDF
2023 S_T J153256-1 Std_Tal_L4 Final Report_Part1.pdf PDF
2023 S_T J153646-1 Std_Tal_L4 Final Report_Part9.pdf PDF
2023 S_T J153646-1 Std_Tal_L4 Final Report_Part2.pdf PDF
2023 S_T J153718-1 Std_Tal_L4 Final Report_Part2.pdf PDF
2023 S_T NB 180-153646-2_BattelleCorp.xls XLS spreadsheet
2023 S_T J153646-1 Std_Tal_L4 Final Report_Part6.pdf PDF
2023 S_T J153256-1 Std_Tal_L4 Final Report_Part4.pdf PDF
2023 S_T NB 180-153718-1_BattelleCorp.xls XLS spreadsheet
2023 S_T J153912-1 Std_Tal_L4 Final Report_Part6.pdf PDF
2023 S_T J153646-1 Std_Tal_L4 Final Report_Part1.pdf PDF
2023 S_T J153718-1 Std_Tal_L4 Final Report_Part7.pdf PDF
2023 S_T J153646-1 Std_Tal_L4 Final Report_Part7.pdf PDF
2023 S_T NB -180-153256-1_BattelleCorp.xls XLS spreadsheet
2023 S_T J153256-1 Std_Tal_L4 Final Report_Part2.pdf PDF
2023 S_T NB 180-153256-2_BattelleCorp.xls XLS spreadsheet
2023 S_T J153256-1 Std_Tal_L4 Final Report_Part3.pdf PDF
2023 S_T J153256-1 Std_Tal_L4 Final Report_Part7.pdf PDF
2023 S_T J153256-1 Std_Tal_L4 Final Report_Part6.pdf PDF
2023 S_T J153912-1 Std_Tal_L4 Final Report_Part4.pdf PDF
2023 S_T J153646-2 Std_Tal_L4 Final Report_Part1.pdf PDF
2023 S_T NB 180-153718-2_BattelleCorp.xls XLS spreadsheet
W912DS23B0009-00001.pdf PDF
2022 ST_NB-Main(42-002)FinalRep_Part7.pdf PDF
Show 40 more

Latest 50 of 103 listed here. See the rest on GovTribe.

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file
Try for free Login

Text version

The file's text, extracted by GovTribe without its formatting.

ANALYTICAL REPORT

PREPARED FOR

Attn: Carole Peven McCarthy

Battelle 141 Longwater Dr

Suite 202 Norwell MA 02061

Generated 5/25/2023 2:30 PM

JOB DESCRIPTION

Newark NJ

JOB NUMBER

180-153912-2

See page two for job notes and contact information.

Pittsburgh PA 15238 RIDC Park 301 Alpha Drive Eurofins Pittsburgh https://eol.et.eurofinsus.com/myEOL/ http://

Eurofins Pittsburgh

Eurofins Pittsburgh is a laboratory within Eurofins Environment Testing Northeast LLC, a company within Eurofins Environment Testing Group of Companies

Job Notes The test results in this report meet all NELAP requirements for parameters for which accreditation is required or available.

Any exceptions to the NELAP requirements are noted in this report. Pursuant to NELAP, this report may not be reproduced, except in full, without the written approval of the laboratory. This report is confidential and is intended for the sole use of Eurofins Environment Testing Northeast, LLC Pittsburgh and its client. All questions regarding this report should be directed to the Eurofins Environment Testing Northeast, LLC Pittsburgh Project Manager or designee who has signed this report.

PA Lab ID: 02-00416

The test results in this report relate only to the samples as received by the laboratory and will meet all requirements of the methodology, with any exceptions noted. This report shall not be reproduced except in full, without the express written approval of the laboratory. All questions should be directed to the Eurofins Pittsburgh Project Manager.

Authorization

Generated

5/25/2023 2:30 PM

Authorized for release by Carrie L Gamber, Senior Project Manager Carrie.Gamber@et.eurofinsus.com 412 963-2428

Table of Contents Cover Title Page

Data Summaries

Definitions

Case Narrative

Detection Summary

Client Sample Results

Toxicity Summary

Default Detection Limits

Surrogate Summary

Isotope Dilution Summary

QC Sample Results

QC Association

Chronicle

Certification Summary

Method Summary

Sample Summary

Manual Integration Summary

Reagent Traceability

COAs

Organic Sample Data

Dioxin

1613B 1613B QC Summary 1613B Sample Data Standards Data

1613B ICAL Data

Table of Contents 1613B Resolution Data 1613B CCAL Data

Raw QC Data 1613B Tune Data 1613B Blank Data 1613B LCS/LCSD Data 1613B MS/MSD Data

1613B Run Logs 1613B Prep Data

Subcontracted Data

Shipping and Receiving Documents

Client Chain of Custody

Sample Receipt Checklist

Definitions/Glossary Job ID: 180-153912-2Client: Battelle

Project/Site: Newark NJ

Qualifiers

Dioxin Qualifier Description

*5- Isotope dilution analyte is outside acceptance limits, low biased.

Qualifier

*5+ Isotope dilution analyte is outside acceptance limits, high biased.

4 MS, MSD: The analyte present in the original sample is greater than 4 times the matrix spike concentration; therefore, control limits are not applicable.

B Compound was found in the blank and sample.

F1 MS and/or MSD recovery exceeds control limits.

G The reported quantitation limit has been raised due to an exhibited elevated noise or matrix interference

I Value is EMPC (estimated maximum possible concentration).

J Result is less than the RL but greater than or equal to the MDL and the concentration is an approximate value.

q The reported result is the estimated maximum possible concentration of this analyte, quantitated using the theoretical ion ratio. The measured ion ratio does not meet qualitative identification criteria and indicates a possible interference.

U Indicates the analyte was analyzed for but not detected.

Glossary These commonly used abbreviations may or may not be present in this report.

¤ Listed under the "D" column to designate that the result is reported on a dry weight basis

Abbreviation

%R Percent Recovery

CFL Contains Free Liquid

CFU Colony Forming Unit

CNF Contains No Free Liquid

DER Duplicate Error Ratio (normalized absolute difference)

Dil Fac Dilution Factor

DL Detection Limit (DoD/DOE)

DL, RA, RE, IN Indicates a Dilution, Re-analysis, Re-extraction, or additional Initial metals/anion analysis of the sample

DLC Decision Level Concentration (Radiochemistry)

EDL Estimated Detection Limit (Dioxin)

LOD Limit of Detection (DoD/DOE)

LOQ Limit of Quantitation (DoD/DOE)

MCL EPA recommended "Maximum Contaminant Level"

MDA Minimum Detectable Activity (Radiochemistry)

MDC Minimum Detectable Concentration (Radiochemistry)

MDL Method Detection Limit

ML Minimum Level (Dioxin)

MPN Most Probable Number

MQL Method Quantitation Limit

NC Not Calculated

ND Not Detected at the reporting limit (or MDL or EDL if shown)

NEG Negative / Absent

POS Positive / Present

PQL Practical Quantitation Limit

PRES Presumptive

QC Quality Control

RER Relative Error Ratio (Radiochemistry)

RL Reporting Limit or Requested Limit (Radiochemistry)

RPD Relative Percent Difference, a measure of the relative difference between two points

TEF Toxicity Equivalent Factor (Dioxin)

TEQ Toxicity Equivalent Quotient (Dioxin)

TNTC Too Numerous To Count

CASE NARRATIVE

Client: Battelle

Project: Newark NJ

Report Number: 180-153912-2

With the exceptions noted as flags or footnotes, standard analytical protocols were followed in the analysis of the samples and no problems were encountered or anomalies observed. In addition all laboratory quality control samples were within established control limits, with any exceptions noted below. Each sample was analyzed to achieve the lowest possible reporting limit within the constraints of the method. In some cases, due to interference or analytes present at high concentrations, samples were diluted. For diluted samples, the reporting limits are adjusted relative to the dilution required.

Calculations are performed before rounding to avoid round-off errors in calculated results.

All holding times were met and proper preservation noted for the methods performed on these samples, unless otherwise detailed in the individual sections below.

RECEIPT

The samples were received on 03/22/2023; the samples arrived in good condition, properly preserved and on ice. The temperatures of the 2 coolers at receipt time were 0.4º C and 1.3º C.

DIOXINS

The following samples went through Gel-Permeation Cleanup procedure, based on EPA method 3640A: #20230172 COMPOSITE E (180-153912-1), #20230172 COMPOSITE E (180-153912-1[MS]), #20230172 COMPOSITE E (180-153912-1[MSD]), #20230173 COMPOSITE G (180-153912-2), #20230179 COMPOSITE M (180-153912-3), #20230184 AMENDED COMPOSITE E (180-153912-4), #20230184 AMENDED COMPOSITE E (180-153912-4[MS]), #20230184 AMENDED COMPOSITE E (180-153912-4[MSD]), #20230186 AMENDED COMPOSITE G (180-153912-5) and #20230192 AMENDED COMPOSITE M (180-153912-6).

One or more Isotope Dilution Analyte (IDA) recoveries are above the method recommended limit for the following sample: #20230192 AMENDED COMPOSITE M (180-153912-6). Quantitation by isotope dilution generally precludes any adverse effect on data quality due to elevated IDA recoveries.

1,2,3,4,7,8-HxCDD, 1,2,3,7,8,9-HxCDD, OCDD and OCDF were detected in method blank LB 140-72228/16-A at levels that were above the method detection limit but below the reporting limit. The values should be considered estimates, and have been flagged. If the associated sample reported a result above the MDL and/or RL, the result has been flagged.

Several analytes were detected in method blank MB 140-72228/18-A at levels that were above the method detection limit but below the reporting limit. The values should be considered estimates, and have been flagged. If the associated sample reported a result above the MDL and/or RL, the result has been flagged.

Several analytes were detected in method blank MB 140-73013/18-A at levels that were above the method detection limit but below the reporting limit. The values should be considered estimates, and have been flagged. If the associated sample reported a result above the MDL and/or RL, the result has been flagged.

1,2,3,4,6,7,8-HpCDF and OCDD failed the recovery criteria low for the MSD of sample #20230172 COMPOSITE EMSD (180-153912-1) in batch 140-73523. The presence of the '4' qualifier indicates analytes where the concentration in the unspiked sample exceeded four times the spiking amount.

1,2,3,4,6,7,8-HpCDF failed the recovery criteria low for the MS of sample #20230184 AMENDED COMPOSITE EMS (180-153912-4) in batch 140-73528. 1,2,3,4,6,7,8-HpCDF, 1,2,3,4,7,8-HxCDF, OCDD and OCDF failed the recovery criteria low for the MSD of sample #20230184 AMENDED COMPOSITE EMSD (180-153912-4) in batch 140-73528. The presence of the '4' qualifier indicates analytes where the concentration in the unspiked sample exceeded four times the spiking amount.

Detection Summary

Project/Site: Newark NJ

Client Sample ID: #20230172 COMPOSITE E Lab Sample ID: 180-153912-1

☼2,3,7,8-TCDD

RL

1.1 pg/g

EDL

0.21

Analyte Result Qualifier Unit Dil Fac D Method Prep Type

Total/NA123 1613B

☼1,2,3,7,8-PeCDD 5.6 pg/g1.2 Total/NA12.8 J q 1613B

☼1,2,3,4,7,8-HxCDD 5.6 pg/g0.50 Total/NA13.8 J B 1613B

☼1,2,3,6,7,8-HxCDD 5.6 pg/g0.43 Total/NA112 B 1613B

☼1,2,3,7,8,9-HxCDD 5.6 pg/g0.43 Total/NA111 B 1613B

☼1,2,3,4,6,7,8-HpCDD 5.6 pg/g0.23 Total/NA1240 1613B

☼OCDD 11 pg/g0.18 Total/NA12700 B 1613B

☼2,3,7,8-TCDF 1.1 pg/g0.39 Total/NA113 1613B

☼1,2,3,7,8-PeCDF 5.6 pg/g0.27 Total/NA16.2 1613B

☼2,3,4,7,8-PeCDF 5.6 pg/g0.25 Total/NA19.7 1613B

☼1,2,3,4,7,8-HxCDF 5.6 pg/g0.26 Total/NA133 1613B

☼1,2,3,6,7,8-HxCDF 5.6 pg/g0.29 Total/NA112 I 1613B

☼2,3,4,6,7,8-HxCDF 5.6 pg/g0.29 Total/NA15.5 J B 1613B

☼1,2,3,4,6,7,8-HpCDF 5.6 pg/g0.53 Total/NA1190 B F1 1613B

☼1,2,3,4,7,8,9-HpCDF 5.6 pg/g0.56 Total/NA16.3 B 1613B

☼OCDF 11 pg/g0.18 Total/NA1320 B 1613B

Client Sample ID: #20230173 COMPOSITE G Lab Sample ID: 180-153912-2

☼2,3,7,8-TCDD

RL

1.1 pg/g

EDL

0.22

Analyte Result Qualifier Unit Dil Fac D Method Prep Type

Total/NA129 1613B

☼1,2,3,7,8-PeCDD 5.3 pg/g1.4 Total/NA12.7 J q 1613B

☼1,2,3,4,7,8-HxCDD 5.3 pg/g0.56 Total/NA13.3 J B 1613B

☼1,2,3,6,7,8-HxCDD 5.3 pg/g0.52 Total/NA112 B 1613B

☼1,2,3,7,8,9-HxCDD 5.3 pg/g0.50 Total/NA19.9 B 1613B

☼1,2,3,4,6,7,8-HpCDD 5.3 pg/g0.14 Total/NA1230 1613B

☼OCDD 11 pg/g0.025 Total/NA12300 B 1613B

☼2,3,7,8-TCDF 1.1 pg/g0.45 Total/NA112 1613B

☼1,2,3,7,8-PeCDF 5.3 pg/g0.35 Total/NA16.2 1613B

☼2,3,4,7,8-PeCDF 5.3 pg/g0.34 Total/NA19.3 1613B

☼1,2,3,4,7,8-HxCDF 5.3 pg/g0.25 Total/NA137 1613B

☼1,2,3,6,7,8-HxCDF 5.3 pg/g0.27 Total/NA113 I 1613B

☼2,3,4,6,7,8-HxCDF 5.3 pg/g0.29 Total/NA15.7 B 1613B

☼1,2,3,7,8,9-HxCDF 5.3 pg/g0.33 Total/NA10.66 J 1613B

☼1,2,3,4,6,7,8-HpCDF 5.3 pg/g0.39 Total/NA1180 B 1613B

☼1,2,3,4,7,8,9-HpCDF 5.3 pg/g0.44 Total/NA16.3 B 1613B

☼OCDF 11 pg/g0.056 Total/NA1280 B 1613B

Client Sample ID: #20230179 COMPOSITE M Lab Sample ID: 180-153912-3

☼2,3,7,8-TCDD

RL

1.8 pg/g

EDL

1.8

Analyte Result Qualifier Unit Dil Fac D Method Prep Type

Total/NA1G96 1613B

☼1,2,3,7,8-PeCDD 6.7 pg/g2.6 Total/NA18.3 q 1613B

☼1,2,3,4,7,8-HxCDD 6.7 pg/g2.8 Total/NA17.3 B 1613B

☼1,2,3,6,7,8-HxCDD 6.7 pg/g2.7 Total/NA130 B 1613B

☼1,2,3,7,8,9-HxCDD 6.7 pg/g2.5 Total/NA122 B 1613B

☼1,2,3,4,6,7,8-HpCDD 6.7 pg/g0.26 Total/NA1510 1613B

☼OCDD 13 pg/g0.20 Total/NA15100 B 1613B

☼2,3,7,8-TCDF 1.3 pg/g0.92 Total/NA145 1613B

☼1,2,3,7,8-PeCDF 6.7 pg/g0.49 Total/NA122 1613B

☼2,3,4,7,8-PeCDF 6.7 pg/g0.43 Total/NA134 1613B

☼1,2,3,4,7,8-HxCDF 6.7 pg/g0.45 Total/NA1110 1613B

Eurofins Pittsburgh

This Detection Summary does not include radiochemical test results.

Project/Site: Newark NJ

Client Sample ID: #20230179 COMPOSITE M (Continued) Lab Sample ID: 180-153912-3

☼1,2,3,6,7,8-HxCDF

RL

6.7 pg/g

EDL

0.51

Analyte Result Qualifier Unit Dil Fac D Method Prep Type

Total/NA1I44 1613B

☼2,3,4,6,7,8-HxCDF 6.7 pg/g0.54 Total/NA122 B 1613B

☼1,2,3,7,8,9-HxCDF 6.7 pg/g0.62 Total/NA12.3 J 1613B

☼1,2,3,4,6,7,8-HpCDF 6.7 pg/g0.48 Total/NA1470 B 1613B

☼1,2,3,4,7,8,9-HpCDF 6.7 pg/g0.55 Total/NA121 B 1613B

☼OCDF 13 pg/g0.18 Total/NA1770 B 1613B

Client Sample ID: #20230184 AMENDED COMPOSITE E Lab Sample ID: 180-153912-4

☼2,3,7,8-TCDD

RL

0.90 pg/g

EDL

0.36

Analyte Result Qualifier Unit Dil Fac D Method Prep Type

Total/NA117 1613B

☼1,2,3,7,8-PeCDD 4.5 pg/g0.78 Total/NA12.1 J q 1613B

☼1,2,3,4,7,8-HxCDD 4.5 pg/g0.33 Total/NA12.8 J B 1613B

☼1,2,3,6,7,8-HxCDD 4.5 pg/g0.32 Total/NA19.7 B 1613B

☼1,2,3,7,8,9-HxCDD 4.5 pg/g0.30 Total/NA18.1 B 1613B

☼1,2,3,4,6,7,8-HpCDD 4.5 pg/g0.12 Total/NA1190 1613B

☼OCDD 9.0 pg/g0.39 Total/NA12100 B 1613B

☼2,3,7,8-TCDF 0.90 pg/g0.19 Total/NA19.0 1613B

☼1,2,3,7,8-PeCDF 4.5 pg/g0.34 Total/NA14.2 J 1613B

☼2,3,4,7,8-PeCDF 4.5 pg/g0.31 Total/NA18.0 1613B

☼1,2,3,4,7,8-HxCDF 4.5 pg/g0.34 Total/NA137 F1 1613B

☼1,2,3,6,7,8-HxCDF 4.5 pg/g0.36 Total/NA111 I 1613B

☼2,3,4,6,7,8-HxCDF 4.5 pg/g0.38 Total/NA14.6 B 1613B

☼1,2,3,4,6,7,8-HpCDF 4.5 pg/g0.86 Total/NA1160 B F1 1613B

☼1,2,3,4,7,8,9-HpCDF 4.5 pg/g0.95 Total/NA15.5 B 1613B

☼OCDF 9.0 pg/g0.13 Total/NA1250 B F1 1613B

OCDD 95 pg/L1.3 SPLP East13.1 J B 1613B

Client Sample ID: #20230186 AMENDED COMPOSITE G Lab Sample ID: 180-153912-5

☼2,3,7,8-TCDD

RL

0.97 pg/g

EDL

0.20

Analyte Result Qualifier Unit Dil Fac D Method Prep Type

Total/NA123 1613B

☼1,2,3,7,8-PeCDD 4.8 pg/g0.84 Total/NA12.3 J q 1613B

☼1,2,3,4,7,8-HxCDD 4.8 pg/g0.44 Total/NA13.2 J B 1613B

☼1,2,3,6,7,8-HxCDD 4.8 pg/g0.40 Total/NA111 B 1613B

☼1,2,3,7,8,9-HxCDD 4.8 pg/g0.39 Total/NA18.8 B 1613B

☼1,2,3,4,6,7,8-HpCDD 4.8 pg/g0.15 Total/NA1210 1613B

☼OCDD 9.7 pg/g0.19 Total/NA12300 B 1613B

☼2,3,7,8-TCDF 0.97 pg/g0.26 Total/NA111 1613B

☼1,2,3,7,8-PeCDF 4.8 pg/g0.22 Total/NA15.4 1613B

☼2,3,4,7,8-PeCDF 4.8 pg/g0.20 Total/NA19.0 1613B

☼1,2,3,4,7,8-HxCDF 4.8 pg/g0.24 Total/NA138 1613B

☼1,2,3,6,7,8-HxCDF 4.8 pg/g0.27 Total/NA112 I 1613B

☼2,3,4,6,7,8-HxCDF 4.8 pg/g0.25 Total/NA15.3 B 1613B

☼1,2,3,7,8,9-HxCDF 4.8 pg/g0.32 Total/NA10.63 J 1613B

☼1,2,3,4,6,7,8-HpCDF 4.8 pg/g0.31 Total/NA1170 B 1613B

☼1,2,3,4,7,8,9-HpCDF 4.8 pg/g0.35 Total/NA16.1 B 1613B

☼OCDF 9.7 pg/g0.20 Total/NA1250 B 1613B

1,2,3,4,7,8-HxCDD 47 pg/L0.44 SPLP East11.2 J B q 1613B

1,2,3,6,7,8-HxCDD 47 pg/L0.41 SPLP East10.90 J B q 1613B

1,2,3,7,8,9-HxCDD 47 pg/L0.39 SPLP East10.76 J B 1613B

OCDD 95 pg/L0.31 SPLP East12.6 J B q 1613B

Eurofins Pittsburgh

Project/Site: Newark NJ

Client Sample ID: #20230186 AMENDED COMPOSITE G (Continued)

Lab Sample ID: 180-153912-5

1,2,3,7,8-PeCDF

RL

47 pg/L

EDL

0.40

Analyte Result Qualifier Unit Dil Fac D Method Prep Type

SPLP East1J B q0.70 1613B

2,3,4,7,8-PeCDF 47 pg/L0.37 SPLP East10.74 J q 1613B

1,2,3,4,6,7,8-HpCDF 47 pg/L0.20 SPLP East10.65 J B q 1613B

1,2,3,4,7,8,9-HpCDF 47 pg/L0.25 SPLP East10.77 J B q 1613B

OCDF 95 pg/L0.31 SPLP East11.2 J B q 1613B

Client Sample ID: #20230192 AMENDED COMPOSITE M Lab Sample ID: 180-153912-6

☼2,3,7,8-TCDD

RL

1.3 pg/g

EDL

1.3

Analyte Result Qualifier Unit Dil Fac D Method Prep Type

Total/NA1G75 1613B

☼1,2,3,7,8-PeCDD 5.7 pg/g2.2 Total/NA14.9 J 1613B

☼1,2,3,4,7,8-HxCDD 5.7 pg/g1.9 Total/NA15.5 J B 1613B

☼1,2,3,6,7,8-HxCDD 5.7 pg/g1.8 Total/NA123 B 1613B

☼1,2,3,7,8,9-HxCDD 5.7 pg/g1.7 Total/NA117 B 1613B

☼1,2,3,4,6,7,8-HpCDD 5.7 pg/g0.32 Total/NA1450 1613B

☼OCDD 11 pg/g0.23 Total/NA14600 B 1613B

☼2,3,7,8-TCDF 1.1 pg/g0.69 Total/NA133 1613B

☼1,2,3,7,8-PeCDF 5.7 pg/g0.37 Total/NA114 1613B

☼2,3,4,7,8-PeCDF 5.7 pg/g0.35 Total/NA123 1613B

☼1,2,3,4,7,8-HxCDF 5.7 pg/g0.39 Total/NA178 I 1613B

☼1,2,3,6,7,8-HxCDF 5.7 pg/g0.44 Total/NA126 1613B

☼2,3,4,6,7,8-HxCDF 5.7 pg/g0.49 Total/NA115 B 1613B

☼1,2,3,7,8,9-HxCDF 5.7 pg/g0.53 Total/NA11.5 J 1613B

☼1,2,3,4,6,7,8-HpCDF 5.7 pg/g0.63 Total/NA1340 B 1613B

☼1,2,3,4,7,8,9-HpCDF 5.7 pg/g0.70 Total/NA114 B 1613B

☼OCDF 11 pg/g0.23 Total/NA1510 B 1613B

1,2,3,4,6,7,8-HpCDF 49 pg/L0.29 SPLP East10.37 J q B 1613B

OCDF 99 pg/L0.24 SPLP East10.99 J B 1613B

Eurofins Pittsburgh

Client Sample Results

Project/Site: Newark NJ

Method: EPA 1613B - Dioxins and Furans (HRGC/HRMS)

Lab Sample ID: 180-153912-1Client Sample ID: #20230172 COMPOSITE E Matrix: SedimentDate Collected: 03/16/23 09:31

Percent Solids: 43.9Date Received: 03/22/23 09:30

RL EDL

23 1.1 0.21 pg/g ☼ 05/07/23 09:15 05/23/23 23:21 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

2,3,7,8-TCDD

5.6 1.2 pg/g 05/07/23 09:15 05/23/23 23:21 1☼2.8 J q1,2,3,7,8-PeCDD

5.6 0.50 pg/g 05/07/23 09:15 05/23/23 23:21 1☼3.8 J B1,2,3,4,7,8-HxCDD

5.6 0.43 pg/g 05/07/23 09:15 05/23/23 23:21 1☼12 B1,2,3,6,7,8-HxCDD

5.6 0.43 pg/g 05/07/23 09:15 05/23/23 23:21 1☼11 B1,2,3,7,8,9-HxCDD

5.6 0.23 pg/g 05/07/23 09:15 05/23/23 23:21 1☼2401,2,3,4,6,7,8-HpCDD

11 0.18 pg/g 05/07/23 09:15 05/23/23 23:21 1☼2700 BOCDD

1.1 0.39 pg/g 05/07/23 09:15 05/24/23 19:18 1☼132,3,7,8-TCDF

5.6 0.27 pg/g 05/07/23 09:15 05/23/23 23:21 1☼6.21,2,3,7,8-PeCDF

5.6 0.25 pg/g 05/07/23 09:15 05/23/23 23:21 1☼9.72,3,4,7,8-PeCDF

5.6 0.26 pg/g 05/07/23 09:15 05/23/23 23:21 1☼331,2,3,4,7,8-HxCDF

5.6 0.29 pg/g 05/07/23 09:15 05/23/23 23:21 1☼12 I1,2,3,6,7,8-HxCDF

5.6 0.29 pg/g 05/07/23 09:15 05/23/23 23:21 1☼5.5 J B2,3,4,6,7,8-HxCDF

5.6 0.33 pg/g 05/07/23 09:15 05/23/23 23:21 1☼5.6 U1,2,3,7,8,9-HxCDF

5.6 0.53 pg/g 05/07/23 09:15 05/23/23 23:21 1☼190 B F11,2,3,4,6,7,8-HpCDF

5.6 0.56 pg/g 05/07/23 09:15 05/23/23 23:21 1☼6.3 B1,2,3,4,7,8,9-HpCDF

11 0.18 pg/g 05/07/23 09:15 05/23/23 23:21 1☼320 BOCDF

13C-2,3,7,8-TCDD 71 25 - 164 05/07/23 09:15 05/23/23 23:21 1

Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery

13C-1,2,3,7,8-PeCDD 75 05/07/23 09:15 05/23/23 23:21 125 - 181

13C-1,2,3,4,7,8-HxCDD 73 05/07/23 09:15 05/23/23 23:21 132 - 141

13C-1,2,3,6,7,8-HxCDD 79 05/07/23 09:15 05/23/23 23:21 128 - 130

13C-1,2,3,4,6,7,8-HpCDD 87 05/07/23 09:15 05/23/23 23:21 123 - 140

13C-OCDD 85 05/07/23 09:15 05/23/23 23:21 117 - 157

13C-2,3,7,8-TCDF 62 05/07/23 09:15 05/23/23 23:21 124 - 169

13C-2,3,7,8-TCDF 64 05/07/23 09:15 05/24/23 19:18 124 - 169

13C-1,2,3,7,8-PeCDF 68 05/07/23 09:15 05/23/23 23:21 124 - 185

13C-2,3,4,7,8-PeCDF 66 05/07/23 09:15 05/23/23 23:21 121 - 178

13C-1,2,3,4,7,8-HxCDF 76 05/07/23 09:15 05/23/23 23:21 126 - 152

13C-1,2,3,6,7,8-HxCDF 64 05/07/23 09:15 05/23/23 23:21 126 - 123

13C-2,3,4,6,7,8-HxCDF 68 05/07/23 09:15 05/23/23 23:21 128 - 136

13C-1,2,3,7,8,9-HxCDF 69 05/07/23 09:15 05/23/23 23:21 129 - 147

13C-1,2,3,4,6,7,8-HpCDF 74 05/07/23 09:15 05/23/23 23:21 128 - 143

13C-1,2,3,4,7,8,9-HpCDF 74 05/07/23 09:15 05/23/23 23:21 126 - 138

13C-OCDF 67 05/07/23 09:15 05/23/23 23:21 117 - 157

37Cl4-2,3,7,8-TCDD 79 35 - 197 05/07/23 09:15 05/23/23 23:21 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

Project/Site: Newark NJ

Method: EPA 1613B - Dioxins and Furans (HRGC/HRMS)

Lab Sample ID: 180-153912-2Client Sample ID: #20230173 COMPOSITE G Matrix: SedimentDate Collected: 03/16/23 13:02

Percent Solids: 46.2Date Received: 03/22/23 09:30

RL EDL

29 1.1 0.22 pg/g ☼ 05/07/23 09:15 05/24/23 05:36 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

2,3,7,8-TCDD

5.3 1.4 pg/g 05/07/23 09:15 05/24/23 05:36 1☼2.7 J q1,2,3,7,8-PeCDD

5.3 0.56 pg/g 05/07/23 09:15 05/24/23 05:36 1☼3.3 J B1,2,3,4,7,8-HxCDD

5.3 0.52 pg/g 05/07/23 09:15 05/24/23 05:36 1☼12 B1,2,3,6,7,8-HxCDD

5.3 0.50 pg/g 05/07/23 09:15 05/24/23 05:36 1☼9.9 B1,2,3,7,8,9-HxCDD

5.3 0.14 pg/g 05/07/23 09:15 05/24/23 05:36 1☼2301,2,3,4,6,7,8-HpCDD

11 0.025 pg/g 05/07/23 09:15 05/24/23 05:36 1☼2300 BOCDD

1.1 0.45 pg/g 05/07/23 09:15 05/24/23 20:45 1☼122,3,7,8-TCDF

5.3 0.35 pg/g 05/07/23 09:15 05/24/23 05:36 1☼6.21,2,3,7,8-PeCDF

5.3 0.34 pg/g 05/07/23 09:15 05/24/23 05:36 1☼9.32,3,4,7,8-PeCDF

5.3 0.25 pg/g 05/07/23 09:15 05/24/23 05:36 1☼371,2,3,4,7,8-HxCDF

5.3 0.27 pg/g 05/07/23 09:15 05/24/23 05:36 1☼13 I1,2,3,6,7,8-HxCDF

5.3 0.29 pg/g 05/07/23 09:15 05/24/23 05:36 1☼5.7 B2,3,4,6,7,8-HxCDF

5.3 0.33 pg/g 05/07/23 09:15 05/24/23 05:36 1☼0.66 J1,2,3,7,8,9-HxCDF

5.3 0.39 pg/g 05/07/23 09:15 05/24/23 05:36 1☼180 B1,2,3,4,6,7,8-HpCDF

5.3 0.44 pg/g 05/07/23 09:15 05/24/23 05:36 1☼6.3 B1,2,3,4,7,8,9-HpCDF

11 0.056 pg/g 05/07/23 09:15 05/24/23 05:36 1☼280 BOCDF

13C-2,3,7,8-TCDD 70 25 - 164 05/07/23 09:15 05/24/23 05:36 1

Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery

13C-1,2,3,7,8-PeCDD 77 05/07/23 09:15 05/24/23 05:36 125 - 181

13C-1,2,3,4,7,8-HxCDD 76 05/07/23 09:15 05/24/23 05:36 132 - 141

13C-1,2,3,6,7,8-HxCDD 77 05/07/23 09:15 05/24/23 05:36 128 - 130

13C-1,2,3,4,6,7,8-HpCDD 81 05/07/23 09:15 05/24/23 05:36 123 - 140

13C-OCDD 88 05/07/23 09:15 05/24/23 05:36 117 - 157

13C-2,3,7,8-TCDF 62 05/07/23 09:15 05/24/23 20:45 124 - 169

13C-1,2,3,7,8-PeCDF 69 05/07/23 09:15 05/24/23 05:36 124 - 185

13C-2,3,4,7,8-PeCDF 70 05/07/23 09:15 05/24/23 05:36 121 - 178

13C-1,2,3,4,7,8-HxCDF 73 05/07/23 09:15 05/24/23 05:36 126 - 152

13C-1,2,3,6,7,8-HxCDF 63 05/07/23 09:15 05/24/23 05:36 126 - 123

13C-2,3,4,6,7,8-HxCDF 67 05/07/23 09:15 05/24/23 05:36 128 - 136

13C-1,2,3,7,8,9-HxCDF 68 05/07/23 09:15 05/24/23 05:36 129 - 147

13C-1,2,3,4,6,7,8-HpCDF 71 05/07/23 09:15 05/24/23 05:36 128 - 143

13C-1,2,3,4,7,8,9-HpCDF 71 05/07/23 09:15 05/24/23 05:36 126 - 138

13C-OCDF 69 05/07/23 09:15 05/24/23 05:36 117 - 157

37Cl4-2,3,7,8-TCDD 79 35 - 197 05/07/23 09:15 05/24/23 05:36 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

Project/Site: Newark NJ

Method: EPA 1613B - Dioxins and Furans (HRGC/HRMS)

Lab Sample ID: 180-153912-3Client Sample ID: #20230179 COMPOSITE M Matrix: SedimentDate Collected: 03/16/23 14:15

Percent Solids: 36.4Date Received: 03/22/23 09:30

RL EDL

96 G 1.8 1.8 pg/g ☼ 05/07/23 09:15 05/24/23 06:36 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

2,3,7,8-TCDD

6.7 2.6 pg/g 05/07/23 09:15 05/24/23 06:36 1☼8.3 q1,2,3,7,8-PeCDD

6.7 2.8 pg/g 05/07/23 09:15 05/24/23 06:36 1☼7.3 B1,2,3,4,7,8-HxCDD

6.7 2.7 pg/g 05/07/23 09:15 05/24/23 06:36 1☼30 B1,2,3,6,7,8-HxCDD

6.7 2.5 pg/g 05/07/23 09:15 05/24/23 06:36 1☼22 B1,2,3,7,8,9-HxCDD

6.7 0.26 pg/g 05/07/23 09:15 05/24/23 06:36 1☼5101,2,3,4,6,7,8-HpCDD

13 0.20 pg/g 05/07/23 09:15 05/24/23 06:36 1☼5100 BOCDD

1.3 0.92 pg/g 05/07/23 09:15 05/24/23 21:14 1☼452,3,7,8-TCDF

6.7 0.49 pg/g 05/07/23 09:15 05/24/23 06:36 1☼221,2,3,7,8-PeCDF

6.7 0.43 pg/g 05/07/23 09:15 05/24/23 06:36 1☼342,3,4,7,8-PeCDF

6.7 0.45 pg/g 05/07/23 09:15 05/24/23 06:36 1☼1101,2,3,4,7,8-HxCDF

6.7 0.51 pg/g 05/07/23 09:15 05/24/23 06:36 1☼44 I1,2,3,6,7,8-HxCDF

6.7 0.54 pg/g 05/07/23 09:15 05/24/23 06:36 1☼22 B2,3,4,6,7,8-HxCDF

6.7 0.62 pg/g 05/07/23 09:15 05/24/23 06:36 1☼2.3 J1,2,3,7,8,9-HxCDF

6.7 0.48 pg/g 05/07/23 09:15 05/24/23 06:36 1☼470 B1,2,3,4,6,7,8-HpCDF

6.7 0.55 pg/g 05/07/23 09:15 05/24/23 06:36 1☼21 B1,2,3,4,7,8,9-HpCDF

13 0.18 pg/g 05/07/23 09:15 05/24/23 06:36 1☼770 BOCDF

13C-2,3,7,8-TCDD 69 25 - 164 05/07/23 09:15 05/24/23 06:36 1

Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery

13C-1,2,3,7,8-PeCDD 72 05/07/23 09:15 05/24/23 06:36 125 - 181

13C-1,2,3,4,7,8-HxCDD 71 05/07/23 09:15 05/24/23 06:36 132 - 141

13C-1,2,3,6,7,8-HxCDD 71 05/07/23 09:15 05/24/23 06:36 128 - 130

13C-1,2,3,4,6,7,8-HpCDD 72 05/07/23 09:15 05/24/23 06:36 123 - 140

13C-OCDD 60 05/07/23 09:15 05/24/23 06:36 117 - 157

13C-2,3,7,8-TCDF 62 05/07/23 09:15 05/24/23 21:14 124 - 169

13C-1,2,3,7,8-PeCDF 64 05/07/23 09:15 05/24/23 06:36 124 - 185

13C-2,3,4,7,8-PeCDF 63 05/07/23 09:15 05/24/23 06:36 121 - 178

13C-1,2,3,4,7,8-HxCDF 73 05/07/23 09:15 05/24/23 06:36 126 - 152

13C-1,2,3,6,7,8-HxCDF 60 05/07/23 09:15 05/24/23 06:36 126 - 123

13C-2,3,4,6,7,8-HxCDF 64 05/07/23 09:15 05/24/23 06:36 128 - 136

13C-1,2,3,7,8,9-HxCDF 65 05/07/23 09:15 05/24/23 06:36 129 - 147

13C-1,2,3,4,6,7,8-HpCDF 65 05/07/23 09:15 05/24/23 06:36 128 - 143

13C-1,2,3,4,7,8,9-HpCDF 60 05/07/23 09:15 05/24/23 06:36 126 - 138

13C-OCDF 46 05/07/23 09:15 05/24/23 06:36 117 - 157

37Cl4-2,3,7,8-TCDD 87 35 - 197 05/07/23 09:15 05/24/23 06:36 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

Project/Site: Newark NJ

Method: EPA 1613B - Dioxins and Furans (HRGC/HRMS)

Lab Sample ID: 180-153912-4Client Sample ID: #20230184 AMENDED COMPOSITE E Matrix: SedimentDate Collected: 03/16/23 09:31

Percent Solids: 54.1Date Received: 03/22/23 09:30

RL EDL

17 0.90 0.36 pg/g ☼ 05/07/23 09:15 05/24/23 07:36 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

2,3,7,8-TCDD

4.5 0.78 pg/g 05/07/23 09:15 05/24/23 07:36 1☼2.1 J q1,2,3,7,8-PeCDD

4.5 0.33 pg/g 05/07/23 09:15 05/24/23 07:36 1☼2.8 J B1,2,3,4,7,8-HxCDD

4.5 0.32 pg/g 05/07/23 09:15 05/24/23 07:36 1☼9.7 B1,2,3,6,7,8-HxCDD

4.5 0.30 pg/g 05/07/23 09:15 05/24/23 07:36 1☼8.1 B1,2,3,7,8,9-HxCDD

4.5 0.12 pg/g 05/07/23 09:15 05/24/23 07:36 1☼1901,2,3,4,6,7,8-HpCDD

9.0 0.39 pg/g 05/07/23 09:15 05/24/23 07:36 1☼2100 BOCDD

0.90 0.19 pg/g 05/07/23 09:15 05/24/23 21:43 1☼9.02,3,7,8-TCDF

4.5 0.34 pg/g 05/07/23 09:15 05/24/23 07:36 1☼4.2 J1,2,3,7,8-PeCDF

4.5 0.31 pg/g 05/07/23 09:15 05/24/23 07:36 1☼8.02,3,4,7,8-PeCDF

4.5 0.34 pg/g 05/07/23 09:15 05/24/23 07:36 1☼37 F11,2,3,4,7,8-HxCDF

4.5 0.36 pg/g 05/07/23 09:15 05/24/23 07:36 1☼11 I1,2,3,6,7,8-HxCDF

4.5 0.38 pg/g 05/07/23 09:15 05/24/23 07:36 1☼4.6 B2,3,4,6,7,8-HxCDF

4.5 0.43 pg/g 05/07/23 09:15 05/24/23 07:36 1☼4.5 U1,2,3,7,8,9-HxCDF

4.5 0.86 pg/g 05/07/23 09:15 05/24/23 07:36 1☼160 B F11,2,3,4,6,7,8-HpCDF

4.5 0.95 pg/g 05/07/23 09:15 05/24/23 07:36 1☼5.5 B1,2,3,4,7,8,9-HpCDF

9.0 0.13 pg/g 05/07/23 09:15 05/24/23 07:36 1☼250 B F1OCDF

13C-2,3,7,8-TCDD 68 25 - 164 05/07/23 09:15 05/24/23 07:36 1

Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery

13C-1,2,3,7,8-PeCDD 76 05/07/23 09:15 05/24/23 07:36 125 - 181

13C-1,2,3,4,7,8-HxCDD 73 05/07/23 09:15 05/24/23 07:36 132 - 141

13C-1,2,3,6,7,8-HxCDD 73 05/07/23 09:15 05/24/23 07:36 128 - 130

13C-1,2,3,4,6,7,8-HpCDD 81 05/07/23 09:15 05/24/23 07:36 123 - 140

13C-OCDD 80 05/07/23 09:15 05/24/23 07:36 117 - 157

13C-2,3,7,8-TCDF 63 05/07/23 09:15 05/24/23 21:43 124 - 169

13C-1,2,3,7,8-PeCDF 67 05/07/23 09:15 05/24/23 07:36 124 - 185

13C-2,3,4,7,8-PeCDF 67 05/07/23 09:15 05/24/23 07:36 121 - 178

13C-1,2,3,4,7,8-HxCDF 71 05/07/23 09:15 05/24/23 07:36 126 - 152

13C-1,2,3,6,7,8-HxCDF 61 05/07/23 09:15 05/24/23 07:36 126 - 123

13C-2,3,4,6,7,8-HxCDF 64 05/07/23 09:15 05/24/23 07:36 128 - 136

13C-1,2,3,7,8,9-HxCDF 66 05/07/23 09:15 05/24/23 07:36 129 - 147

13C-1,2,3,4,6,7,8-HpCDF 69 05/07/23 09:15 05/24/23 07:36 128 - 143

13C-1,2,3,4,7,8,9-HpCDF 69 05/07/23 09:15 05/24/23 07:36 126 - 138

13C-OCDF 62 05/07/23 09:15 05/24/23 07:36 117 - 157

37Cl4-2,3,7,8-TCDD 77 35 - 197 05/07/23 09:15 05/24/23 07:36 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

Project/Site: Newark NJ

Method: EPA 1613B - Dioxins and Furans (HRGC/HRMS)

Lab Sample ID: 180-153912-5Client Sample ID: #20230186 AMENDED COMPOSITE G Matrix: SedimentDate Collected: 03/16/23 13:02

Percent Solids: 51.5Date Received: 03/22/23 09:30

RL EDL

23 0.97 0.20 pg/g ☼ 05/07/23 09:15 05/24/23 08:36 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

2,3,7,8-TCDD

4.8 0.84 pg/g 05/07/23 09:15 05/24/23 08:36 1☼2.3 J q1,2,3,7,8-PeCDD

4.8 0.44 pg/g 05/07/23 09:15 05/24/23 08:36 1☼3.2 J B1,2,3,4,7,8-HxCDD

4.8 0.40 pg/g 05/07/23 09:15 05/24/23 08:36 1☼11 B1,2,3,6,7,8-HxCDD

4.8 0.39 pg/g 05/07/23 09:15 05/24/23 08:36 1☼8.8 B1,2,3,7,8,9-HxCDD

4.8 0.15 pg/g 05/07/23 09:15 05/24/23 08:36 1☼2101,2,3,4,6,7,8-HpCDD

9.7 0.19 pg/g 05/07/23 09:15 05/24/23 08:36 1☼2300 BOCDD

0.97 0.26 pg/g 05/07/23 09:15 05/24/23 23:11 1☼112,3,7,8-TCDF

4.8 0.22 pg/g 05/07/23 09:15 05/24/23 08:36 1☼5.41,2,3,7,8-PeCDF

4.8 0.20 pg/g 05/07/23 09:15 05/24/23 08:36 1☼9.02,3,4,7,8-PeCDF

4.8 0.24 pg/g 05/07/23 09:15 05/24/23 08:36 1☼381,2,3,4,7,8-HxCDF

4.8 0.27 pg/g 05/07/23 09:15 05/24/23 08:36 1☼12 I1,2,3,6,7,8-HxCDF

4.8 0.25 pg/g 05/07/23 09:15 05/24/23 08:36 1☼5.3 B2,3,4,6,7,8-HxCDF

4.8 0.32 pg/g 05/07/23 09:15 05/24/23 08:36 1☼0.63 J1,2,3,7,8,9-HxCDF

4.8 0.31 pg/g 05/07/23 09:15 05/24/23 08:36 1☼170 B1,2,3,4,6,7,8-HpCDF

4.8 0.35 pg/g 05/07/23 09:15 05/24/23 08:36 1☼6.1 B1,2,3,4,7,8,9-HpCDF

9.7 0.20 pg/g 05/07/23 09:15 05/24/23 08:36 1☼250 BOCDF

13C-2,3,7,8-TCDD 68 25 - 164 05/07/23 09:15 05/24/23 08:36 1

Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery

13C-1,2,3,7,8-PeCDD 75 05/07/23 09:15 05/24/23 08:36 125 - 181

13C-1,2,3,4,7,8-HxCDD 74 05/07/23 09:15 05/24/23 08:36 132 - 141

13C-1,2,3,6,7,8-HxCDD 75 05/07/23 09:15 05/24/23 08:36 128 - 130

13C-1,2,3,4,6,7,8-HpCDD 82 05/07/23 09:15 05/24/23 08:36 123 - 140

13C-OCDD 87 05/07/23 09:15 05/24/23 08:36 117 - 157

13C-2,3,7,8-TCDF 60 05/07/23 09:15 05/24/23 23:11 124 - 169

13C-1,2,3,7,8-PeCDF 66 05/07/23 09:15 05/24/23 08:36 124 - 185

13C-2,3,4,7,8-PeCDF 67 05/07/23 09:15 05/24/23 08:36 121 - 178

13C-1,2,3,4,7,8-HxCDF 73 05/07/23 09:15 05/24/23 08:36 126 - 152

13C-1,2,3,6,7,8-HxCDF 60 05/07/23 09:15 05/24/23 08:36 126 - 123

13C-2,3,4,6,7,8-HxCDF 66 05/07/23 09:15 05/24/23 08:36 128 - 136

13C-1,2,3,7,8,9-HxCDF 65 05/07/23 09:15 05/24/23 08:36 129 - 147

13C-1,2,3,4,6,7,8-HpCDF 70 05/07/23 09:15 05/24/23 08:36 128 - 143

13C-1,2,3,4,7,8,9-HpCDF 69 05/07/23 09:15 05/24/23 08:36 126 - 138

13C-OCDF 66 05/07/23 09:15 05/24/23 08:36 117 - 157

37Cl4-2,3,7,8-TCDD 79 35 - 197 05/07/23 09:15 05/24/23 08:36 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

Project/Site: Newark NJ

Method: EPA 1613B - Dioxins and Furans (HRGC/HRMS)

Lab Sample ID: 180-153912-6Client Sample ID: #20230192 AMENDED COMPOSITE M Matrix: SedimentDate Collected: 03/16/23 14:15

Percent Solids: 43.4Date Received: 03/22/23 09:30

RL EDL

75 G 1.3 1.3 pg/g ☼ 05/07/23 09:15 05/24/23 09:36 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

2,3,7,8-TCDD

5.7 2.2 pg/g 05/07/23 09:15 05/24/23 09:36 1☼4.9 J1,2,3,7,8-PeCDD

5.7 1.9 pg/g 05/07/23 09:15 05/24/23 09:36 1☼5.5 J B1,2,3,4,7,8-HxCDD

5.7 1.8 pg/g 05/07/23 09:15 05/24/23 09:36 1☼23 B1,2,3,6,7,8-HxCDD

5.7 1.7 pg/g 05/07/23 09:15 05/24/23 09:36 1☼17 B1,2,3,7,8,9-HxCDD

5.7 0.32 pg/g 05/07/23 09:15 05/24/23 09:36 1☼4501,2,3,4,6,7,8-HpCDD

11 0.23 pg/g 05/07/23 09:15 05/24/23 09:36 1☼4600 BOCDD

1.1 0.69 pg/g 05/07/23 09:15 05/24/23 23:40 1☼332,3,7,8-TCDF

5.7 0.37 pg/g 05/07/23 09:15 05/24/23 09:36 1☼141,2,3,7,8-PeCDF

5.7 0.35 pg/g 05/07/23 09:15 05/24/23 09:36 1☼232,3,4,7,8-PeCDF

5.7 0.39 pg/g 05/07/23 09:15 05/24/23 09:36 1☼78 I1,2,3,4,7,8-HxCDF

5.7 0.44 pg/g 05/07/23 09:15 05/24/23 09:36 1☼261,2,3,6,7,8-HxCDF

5.7 0.49 pg/g 05/07/23 09:15 05/24/23 09:36 1☼15 B2,3,4,6,7,8-HxCDF

5.7 0.53 pg/g 05/07/23 09:15 05/24/23 09:36 1☼1.5 J1,2,3,7,8,9-HxCDF

5.7 0.63 pg/g 05/07/23 09:15 05/24/23 09:36 1☼340 B1,2,3,4,6,7,8-HpCDF

5.7 0.70 pg/g 05/07/23 09:15 05/24/23 09:36 1☼14 B1,2,3,4,7,8,9-HpCDF

11 0.23 pg/g 05/07/23 09:15 05/24/23 09:36 1☼510 BOCDF

13C-2,3,7,8-TCDD 67 25 - 164 05/07/23 09:15 05/24/23 09:36 1

Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery

13C-1,2,3,7,8-PeCDD 66 05/07/23 09:15 05/24/23 09:36 125 - 181

13C-1,2,3,4,7,8-HxCDD 70 05/07/23 09:15 05/24/23 09:36 132 - 141

13C-1,2,3,6,7,8-HxCDD 72 05/07/23 09:15 05/24/23 09:36 128 - 130

13C-1,2,3,4,6,7,8-HpCDD 72 05/07/23 09:15 05/24/23 09:36 123 - 140

13C-OCDD 56 05/07/23 09:15 05/24/23 09:36 117 - 157

13C-2,3,7,8-TCDF 174 *5+ 05/07/23 09:15 05/24/23 23:40 124 - 169

13C-1,2,3,7,8-PeCDF 61 05/07/23 09:15 05/24/23 09:36 124 - 185

13C-2,3,4,7,8-PeCDF 59 05/07/23 09:15 05/24/23 09:36 121 - 178

13C-1,2,3,4,7,8-HxCDF 72 05/07/23 09:15 05/24/23 09:36 126 - 152

13C-1,2,3,6,7,8-HxCDF 60 05/07/23 09:15 05/24/23 09:36 126 - 123

13C-2,3,4,6,7,8-HxCDF 62 05/07/23 09:15 05/24/23 09:36 128 - 136

13C-1,2,3,7,8,9-HxCDF 62 05/07/23 09:15 05/24/23 09:36 129 - 147

13C-1,2,3,4,6,7,8-HpCDF 66 05/07/23 09:15 05/24/23 09:36 128 - 143

13C-1,2,3,4,7,8,9-HpCDF 59 05/07/23 09:15 05/24/23 09:36 126 - 138

13C-OCDF 43 05/07/23 09:15 05/24/23 09:36 117 - 157

37Cl4-2,3,7,8-TCDD 88 35 - 197 05/07/23 09:15 05/24/23 09:36 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

Project/Site: Newark NJ

Method: EPA 1613B - Dioxins and Furans (HRGC/HRMS) - SPLP East

Lab Sample ID: 180-153912-4Client Sample ID: #20230184 AMENDED COMPOSITE E Matrix: SedimentDate Collected: 03/16/23 09:31

Date Received: 03/22/23 09:30

RL EDL

9.5 U 9.5 0.47 pg/L 04/13/23 09:23 05/04/23 07:04 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

2,3,7,8-TCDD

47 0.42 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,7,8-PeCDD

47 0.76 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,4,7,8-HxCDD

47 0.72 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,6,7,8-HxCDD

47 0.69 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,7,8,9-HxCDD

47 3.1 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,4,6,7,8-HpCDD

95 1.3 pg/L 04/13/23 09:23 05/04/23 07:04 13.1 J BOCDD

9.5 0.53 pg/L 04/13/23 09:23 05/04/23 07:04 19.5 U2,3,7,8-TCDF

47 0.38 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,7,8-PeCDF

47 0.35 pg/L 04/13/23 09:23 05/04/23 07:04 147 U2,3,4,7,8-PeCDF

47 0.39 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,4,7,8-HxCDF

47 0.43 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,6,7,8-HxCDF

47 0.45 pg/L 04/13/23 09:23 05/04/23 07:04 147 U2,3,4,6,7,8-HxCDF

47 0.58 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,7,8,9-HxCDF

47 1.9 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,4,6,7,8-HpCDF

47 2.6 pg/L 04/13/23 09:23 05/04/23 07:04 147 U1,2,3,4,7,8,9-HpCDF

95 0.27 pg/L 04/13/23 09:23 05/04/23 07:04 195 UOCDF

13C-2,3,7,8-TCDD 64 25 - 164 04/13/23 09:23 05/04/23 07:04 1

Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery

13C-1,2,3,7,8-PeCDD 66 04/13/23 09:23 05/04/23 07:04 125 - 181

13C-1,2,3,4,7,8-HxCDD 64 04/13/23 09:23 05/04/23 07:04 132 - 141

13C-1,2,3,6,7,8-HxCDD 70 04/13/23 09:23 05/04/23 07:04 128 - 130

13C-1,2,3,4,6,7,8-HpCDD 69 04/13/23 09:23 05/04/23 07:04 123 - 140

13C-OCDD 75 04/13/23 09:23 05/04/23 07:04 117 - 157

13C-2,3,7,8-TCDF 67 04/13/23 09:23 05/04/23 07:04 124 - 169

13C-1,2,3,7,8-PeCDF 66 04/13/23 09:23 05/04/23 07:04 124 - 185

13C-2,3,4,7,8-PeCDF 64 04/13/23 09:23 05/04/23 07:04 121 - 178

13C-1,2,3,4,7,8-HxCDF 71 04/13/23 09:23 05/04/23 07:04 126 - 152

13C-1,2,3,6,7,8-HxCDF 66 04/13/23 09:23 05/04/23 07:04 126 - 123

13C-2,3,4,6,7,8-HxCDF 67 04/13/23 09:23 05/04/23 07:04 128 - 136

13C-1,2,3,7,8,9-HxCDF 62 04/13/23 09:23 05/04/23 07:04 129 - 147

13C-1,2,3,4,6,7,8-HpCDF 70 04/13/23 09:23 05/04/23 07:04 128 - 143

13C-1,2,3,4,7,8,9-HpCDF 61 04/13/23 09:23 05/04/23 07:04 126 - 138

13C-OCDF 62 04/13/23 09:23 05/04/23 07:04 117 - 157

37Cl4-2,3,7,8-TCDD 84 35 - 197 04/13/23 09:23 05/04/23 07:04 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

Project/Site: Newark NJ

Method: EPA 1613B - Dioxins and Furans (HRGC/HRMS) - SPLP East

Lab Sample ID: 180-153912-5Client Sample ID: #20230186 AMENDED COMPOSITE G Matrix: SedimentDate Collected: 03/16/23 13:02

Date Received: 03/22/23 09:30

RL EDL

9.5 U 9.5 0.94 pg/L 04/13/23 09:23 05/04/23 05:04 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

2,3,7,8-TCDD

47 0.50 pg/L 04/13/23 09:23 05/04/23 05:04 147 U1,2,3,7,8-PeCDD

47 0.44 pg/L 04/13/23 09:23 05/04/23 05:04 11.2 J B q1,2,3,4,7,8-HxCDD

47 0.41 pg/L 04/13/23 09:23 05/04/23 05:04 10.90 J B q1,2,3,6,7,8-HxCDD

47 0.39 pg/L 04/13/23 09:23 05/04/23 05:04 10.76 J B1,2,3,7,8,9-HxCDD

47 0.28 pg/L 04/13/23 09:23 05/04/23 05:04 147 U1,2,3,4,6,7,8-HpCDD

95 0.31 pg/L 04/13/23 09:23 05/04/23 05:04 12.6 J B qOCDD

9.5 1.1 pg/L 04/13/23 09:23 05/04/23 05:04 19.5 U2,3,7,8-TCDF

47 0.40 pg/L 04/13/23 09:23 05/04/23 05:04 10.70 J B q1,2,3,7,8-PeCDF

47 0.37 pg/L 04/13/23 09:23 05/04/23 05:04 10.74 J q2,3,4,7,8-PeCDF

47 0.73 pg/L 04/13/23 09:23 05/04/23 05:04 147 U1,2,3,4,7,8-HxCDF

47 0.77 pg/L 04/13/23 09:23 05/04/23 05:04 147 U1,2,3,6,7,8-HxCDF

47 0.78 pg/L 04/13/23 09:23 05/04/23 05:04 147 U2,3,4,6,7,8-HxCDF

47 0.97 pg/L 04/13/23 09:23 05/04/23 05:04 147 U1,2,3,7,8,9-HxCDF

47 0.20 pg/L 04/13/23 09:23 05/04/23 05:04 10.65 J B q1,2,3,4,6,7,8-HpCDF

47 0.25 pg/L 04/13/23 09:23 05/04/23 05:04 10.77 J B q1,2,3,4,7,8,9-HpCDF

95 0.31 pg/L 04/13/23 09:23 05/04/23 05:04 11.2 J B qOCDF

13C-2,3,7,8-TCDD 65 25 - 164 04/13/23 09:23 05/04/23 05:04 1

Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery

13C-1,2,3,7,8-PeCDD 65 04/13/23 09:23 05/04/23 05:04 125 - 181

13C-1,2,3,4,7,8-HxCDD 64 04/13/23 09:23 05/04/23 05:04 132 - 141

13C-1,2,3,6,7,8-HxCDD 69 04/13/23 09:23 05/04/23 05:04 128 - 130

13C-1,2,3,4,6,7,8-HpCDD 71 04/13/23 09:23 05/04/23 05:04 123 - 140

13C-OCDD 71 04/13/23 09:23 05/04/23 05:04 117 - 157

13C-2,3,7,8-TCDF 66 04/13/23 09:23 05/04/23 05:04 124 - 169

13C-1,2,3,7,8-PeCDF 66 04/13/23 09:23 05/04/23 05:04 124 - 185

13C-2,3,4,7,8-PeCDF 64 04/13/23 09:23 05/04/23 05:04 121 - 178

13C-1,2,3,4,7,8-HxCDF 68 04/13/23 09:23 05/04/23 05:04 126 - 152

13C-1,2,3,6,7,8-HxCDF 63 04/13/23 09:23 05/04/23 05:04 126 - 123

13C-2,3,4,6,7,8-HxCDF 66 04/13/23 09:23 05/04/23 05:04 128 - 136

13C-1,2,3,7,8,9-HxCDF 65 04/13/23 09:23 05/04/23 05:04 129 - 147

13C-1,2,3,4,6,7,8-HpCDF 68 04/13/23 09:23 05/04/23 05:04 128 - 143

13C-1,2,3,4,7,8,9-HpCDF 63 04/13/23 09:23 05/04/23 05:04 126 - 138

13C-OCDF 61 04/13/23 09:23 05/04/23 05:04 117 - 157

37Cl4-2,3,7,8-TCDD 86 35 - 197 04/13/23 09:23 05/04/23 05:04 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

Project/Site: Newark NJ

Method: EPA 1613B - Dioxins and Furans (HRGC/HRMS) - SPLP East

Lab Sample ID: 180-153912-6Client Sample ID: #20230192 AMENDED COMPOSITE M Matrix: SedimentDate Collected: 03/16/23 14:15

Date Received: 03/22/23 09:30

RL EDL

9.9 U 9.9 0.70 pg/L 04/13/23 09:23 05/04/23 06:04 1

Analyte Dil FacAnalyzedPreparedUnit DResult Qualifier

2,3,7,8-TCDD

49 0.76 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,7,8-PeCDD

49 1.2 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,4,7,8-HxCDD

49 1.1 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,6,7,8-HxCDD

49 1.1 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,7,8,9-HxCDD

49 1.1 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,4,6,7,8-HpCDD

99 3.3 pg/L 04/13/23 09:23 05/04/23 06:04 199 UOCDD

9.9 0.57 pg/L 04/13/23 09:23 05/04/23 06:04 19.9 U2,3,7,8-TCDF

49 0.27 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,7,8-PeCDF

49 0.26 pg/L 04/13/23 09:23 05/04/23 06:04 149 U2,3,4,7,8-PeCDF

49 0.35 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,4,7,8-HxCDF

49 0.37 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,6,7,8-HxCDF

49 0.43 pg/L 04/13/23 09:23 05/04/23 06:04 149 U2,3,4,6,7,8-HxCDF

49 0.50 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,7,8,9-HxCDF

49 0.29 pg/L 04/13/23 09:23 05/04/23 06:04 10.37 J q B1,2,3,4,6,7,8-HpCDF

49 0.35 pg/L 04/13/23 09:23 05/04/23 06:04 149 U1,2,3,4,7,8,9-HpCDF

99 0.24 pg/L 04/13/23 09:23 05/04/23 06:04 10.99 J BOCDF

13C-2,3,7,8-TCDD 67 25 - 164 04/13/23 09:23 05/04/23 06:04 1

Isotope Dilution Dil FacAnalyzedPreparedQualifier Limits%Recovery

13C-1,2,3,7,8-PeCDD 63 04/13/23 09:23 05/04/23 06:04 125 - 181

13C-1,2,3,4,7,8-HxCDD 66 04/13/23 09:23 05/04/23 06:04 132 - 141

13C-1,2,3,6,7,8-HxCDD 69 04/13/23 09:23 05/04/23 06:04 128 - 130

13C-1,2,3,4,6,7,8-HpCDD 70 04/13/23 09:23 05/04/23 06:04 123 - 140

13C-OCDD 74 04/13/23 09:23 05/04/23 06:04 117 - 157

13C-2,3,7,8-TCDF 65 04/13/23 09:23 05/04/23 06:04 124 - 169

13C-1,2,3,7,8-PeCDF 66 04/13/23 09:23 05/04/23 06:04 124 - 185

13C-2,3,4,7,8-PeCDF 62 04/13/23 09:23 05/04/23 06:04 121 - 178

13C-1,2,3,4,7,8-HxCDF 71 04/13/23 09:23 05/04/23 06:04 126 - 152

13C-1,2,3,6,7,8-HxCDF 64 04/13/23 09:23 05/04/23 06:04 126 - 123

13C-2,3,4,6,7,8-HxCDF 63 04/13/23 09:23 05/04/23 06:04 128 - 136

13C-1,2,3,7,8,9-HxCDF 65 04/13/23 09:23 05/04/23 06:04 129 - 147

13C-1,2,3,4,6,7,8-HpCDF 71 04/13/23 09:23 05/04/23 06:04 128 - 143

13C-1,2,3,4,7,8,9-HpCDF 64 04/13/23 09:23 05/04/23 06:04 126 - 138

13C-OCDF 62 04/13/23 09:23 05/04/23 06:04 117 - 157

37Cl4-2,3,7,8-TCDD 85 35 - 197 04/13/23 09:23 05/04/23 06:04 1

Surrogate Dil FacAnalyzedPreparedQualifier Limits%Recovery

Toxicity Summary

Project/Site: Newark NJ

Client Sample ID: #20230172 COMPOSITE E Lab Sample ID: 180-153912-1

Analyte

2,3,7,8-TCDD

Result

Qualifier Unit pg/g 23

TEF

WHO 2010

MethodRL

1.1 1

TEQ

0.21

EDL

ND = 0

1613B

1,2,3,7,8-PeCDD 2.8 J q pg/g 2.815.6 1.2 1613B

1,2,3,4,7,8-HxCDD 3.8 J B pg/g 0.380.15.6 0.50 1613B

1,2,3,6,7,8-HxCDD 12 B pg/g 1.20.15.6 0.43 1613B

1,2,3,7,8,9-HxCDD 11 B pg/g 1.10.15.6 0.43 1613B

1,2,3,4,6,7,8-HpCDD 240 pg/g 2.40.015.6 0.23 1613B

OCDD 2700 B pg/g 0.810.000311 0.18 1613B

2,3,7,8-TCDF 13 pg/g 1.30.11.1 0.39 1613B

1,2,3,7,8-PeCDF 6.2 pg/g 0.190.035.6 0.27 1613B

2,3,4,7,8-PeCDF 9.7 pg/g 2.90.35.6 0.25 1613B

1,2,3,4,7,8-HxCDF 33 pg/g 3.30.15.6 0.26 1613B

1,2,3,6,7,8-HxCDF 12 I pg/g 1.20.15.6 0.29 1613B

2,3,4,6,7,8-HxCDF 5.5 J B pg/g 0.550.15.6 0.29 1613B

1,2,3,7,8,9-HxCDF 5.6 U pg/g 0.000.15.6 0.33 1613B

1,2,3,4,6,7,8-HpCDF 190 B F1 pg/g 1.90.015.6 0.53 1613B

1,2,3,4,7,8,9-HpCDF 6.3 B pg/g 0.0630.015.6 0.56 1613B

OCDF 320 B pg/g 0.0960.000311 0.18 1613B

Analyte

Total Toxic Dioxins and Furans

Result Qualifier Unit pg/g 43

TEF

WHO 2010

MethodNONE TEQNONE

ND = 0

TEQ

Client Sample ID: #20230173 COMPOSITE G Lab Sample ID: 180-153912-2

Analyte

2,3,7,8-TCDD

Result

Qualifier Unit pg/g 29

TEF

WHO 2010

MethodRL

1.1 1

TEQ

0.22

EDL

ND = 0

1613B

1,2,3,7,8-PeCDD 2.7 J q pg/g 2.715.3 1.4 1613B

1,2,3,4,7,8-HxCDD 3.3 J B pg/g 0.330.15.3 0.56 1613B

1,2,3,6,7,8-HxCDD 12 B pg/g 1.20.15.3 0.52 1613B

1,2,3,7,8,9-HxCDD 9.9 B pg/g 0.990.15.3 0.50 1613B

1,2,3,4,6,7,8-HpCDD 230 pg/g 2.30.015.3 0.14 1613B

OCDD 2300 B pg/g 0.690.000311 0.025 1613B

2,3,7,8-TCDF 12 pg/g 1.20.11.1 0.45 1613B

1,2,3,7,8-PeCDF 6.2 pg/g 0.190.035.3 0.35 1613B

2,3,4,7,8-PeCDF 9.3 pg/g 2.80.35.3 0.34 1613B

1,2,3,4,7,8-HxCDF 37 pg/g 3.70.15.3 0.25 1613B

1,2,3,6,7,8-HxCDF 13 I pg/g 1.30.15.3 0.27 1613B

2,3,4,6,7,8-HxCDF 5.7 B pg/g 0.570.15.3 0.29 1613B

1,2,3,7,8,9-HxCDF 0.66 J pg/g 0.0660.15.3 0.33 1613B

1,2,3,4,6,7,8-HpCDF 180 B pg/g 1.80.015.3 0.39 1613B

1,2,3,4,7,8,9-HpCDF 6.3 B pg/g 0.0630.015.3 0.44 1613B

OCDF 280 B pg/g 0.0840.000311 0.056 1613B

Eurofins Pittsburgh

TEF Reference:

WHO 2010 = World Health Organization (WHO) 2010 TEF, Dioxins, Furans and PCB Congeners

Project/Site: Newark NJ

Client Sample ID: #20230173 COMPOSITE G (Continued) Lab Sample ID: 180-153912-2

Analyte

Total Toxic Dioxins and Furans

Result Qualifier Unit pg/g 49

TEF

WHO 2010

MethodNONE TEQNONE

ND = 0

TEQ

Client Sample ID: #20230179 COMPOSITE M Lab Sample ID: 180-153912-3

Analyte

2,3,7,8-TCDD

Result

Qualifier

G

Unit pg/g 96

TEF

WHO 2010

MethodRL

1.8 1

TEQ

1.8

EDL

ND = 0

1613B

1,2,3,7,8-PeCDD 8.3 q pg/g 8.316.7 2.6 1613B

1,2,3,4,7,8-HxCDD 7.3 B pg/g 0.730.16.7 2.8 1613B

1,2,3,6,7,8-HxCDD 30 B pg/g 3.00.16.7 2.7 1613B

1,2,3,7,8,9-HxCDD 22 B pg/g 2.20.16.7 2.5 1613B

1,2,3,4,6,7,8-HpCDD 510 pg/g 5.10.016.7 0.26 1613B

OCDD 5100 B pg/g 1.50.000313 0.20 1613B

2,3,7,8-TCDF 45 pg/g 4.50.11.3 0.92 1613B

1,2,3,7,8-PeCDF 22 pg/g 0.660.036.7 0.49 1613B

2,3,4,7,8-PeCDF 34 pg/g 100.36.7 0.43 1613B

1,2,3,4,7,8-HxCDF 110 pg/g 110.16.7 0.45 1613B

1,2,3,6,7,8-HxCDF 44 I pg/g 4.40.16.7 0.51 1613B

2,3,4,6,7,8-HxCDF 22 B pg/g 2.20.16.7 0.54 1613B

1,2,3,7,8,9-HxCDF 2.3 J pg/g 0.230.16.7 0.62 1613B

1,2,3,4,6,7,8-HpCDF 470 B pg/g 4.70.016.7 0.48 1613B

1,2,3,4,7,8,9-HpCDF 21 B pg/g 0.210.016.7 0.55 1613B

OCDF 770 B pg/g 0.230.000313 0.18 1613B

Analyte

Total Toxic Dioxins and Furans

Result Qualifier Unit pg/g 150

TEF

WHO 2010

MethodNONE TEQNONE

ND = 0

TEQ

Client Sample ID: #20230184 AMENDED COMPOSITE E Lab Sample ID: 180-153912-4

Analyte

2,3,7,8-TCDD

Result

Qualifier Unit pg/g 17

TEF

WHO 2010

MethodRL

0.90 1

TEQ

0.36

EDL

ND = 0

1613B

1,2,3,7,8-PeCDD 2.1 J q pg/g 2.114.5 0.78 1613B

1,2,3,4,7,8-HxCDD 2.8 J B pg/g 0.280.14.5 0.33 1613B

1,2,3,6,7,8-HxCDD 9.7 B pg/g 0.970.14.5 0.32 1613B

1,2,3,7,8,9-HxCDD 8.1 B pg/g 0.810.14.5 0.30 1613B

1,2,3,4,6,7,8-HpCDD 190 pg/g 1.90.014.5 0.12 1613B

OCDD 2100 B pg/g 0.630.00039.0 0.39 1613B

2,3,7,8-TCDF 9.0 pg/g 0.900.10.90 0.19 1613B

1,2,3,7,8-PeCDF 4.2 J pg/g 0.130.034.5 0.34 1613B

2,3,4,7,8-PeCDF 8.0 pg/g 2.40.34.5 0.31 1613B

1,2,3,4,7,8-HxCDF 37 F1 pg/g 3.70.14.5 0.34 1613B

1,2,3,6,7,8-HxCDF 11 I pg/g 1.10.14.5 0.36 1613B

Eurofins Pittsburgh

TEF Reference:

Project/Site: Newark NJ

Client Sample ID: #20230184 AMENDED COMPOSITE E (Continued)

Lab Sample ID: 180-153912-4

Analyte

2,3,4,6,7,8-HxCDF

Result

4.6

Qualifier

B

Unit pg/g 0.46

TEF

WHO 2010

MethodRL

4.5 0.1

TEQ

0.38

EDL

ND = 0

1613B

1,2,3,7,8,9-HxCDF 4.5 U pg/g 0.000.14.5 0.43 1613B

1,2,3,4,6,7,8-HpCDF 160 B F1 pg/g 1.60.014.5 0.86 1613B

1,2,3,4,7,8,9-HpCDF 5.5 B pg/g 0.0550.014.5 0.95 1613B

OCDF 250 B F1 pg/g 0.0750.00039.0 0.13 1613B

Analyte

Total Toxic Dioxins and Furans

Result Qualifier Unit pg/g 34

TEF

WHO 2010

MethodNONE TEQNONE

ND = 0

TEQ

Client Sample ID: #20230184 AMENDED COMPOSITE E Lab Sample ID: 180-153912-4

Prep Type: SPLP East

Analyte

2,3,7,8-TCDD

Result

9.5

Qualifier

U

Unit pg/L 0.00

TEF

WHO 2010

MethodRL

9.5 1

TEQ

0.47

EDL

ND = 0

1613B

1,2,3,7,8-PeCDD 47 U pg/L 0.00147 0.42 1613B

1,2,3,4,7,8-HxCDD 47 U pg/L 0.000.147 0.76 1613B

1,2,3,6,7,8-HxCDD 47 U pg/L 0.000.147 0.72 1613B

1,2,3,7,8,9-HxCDD 47 U pg/L 0.000.147 0.69 1613B

1,2,3,4,6,7,8-HpCDD 47 U pg/L 0.000.0147 3.1 1613B

OCDD 3.1 J B pg/L 0.000930.000395 1.3 1613B

2,3,7,8-TCDF 9.5 U pg/L 0.000.19.5 0.53 1613B

1,2,3,7,8-PeCDF 47 U pg/L 0.000.0347 0.38 1613B

2,3,4,7,8-PeCDF 47 U pg/L 0.000.347 0.35 1613B

1,2,3,4,7,8-HxCDF 47 U pg/L 0.000.147 0.39 1613B

1,2,3,6,7,8-HxCDF 47 U pg/L 0.000.147 0.43 1613B

2,3,4,6,7,8-HxCDF 47 U pg/L 0.000.147 0.45 1613B

1,2,3,7,8,9-HxCDF 47 U pg/L 0.000.147 0.58 1613B

1,2,3,4,6,7,8-HpCDF 47 U pg/L 0.000.0147 1.9 1613B

1,2,3,4,7,8,9-HpCDF 47 U pg/L 0.000.0147 2.6 1613B

OCDF 95 U pg/L 0.000.000395 0.27 1613B

Analyte

Total Toxic Dioxins and Furans

Result Qualifier Unit pg/L 0.00093

TEF

WHO 2010

MethodNONE TEQNONE

ND = 0

TEQ

Client Sample ID: #20230186 AMENDED COMPOSITE G Lab Sample ID: 180-153912-5

Analyte

2,3,7,8-TCDD

Result

Qualifier Unit pg/g 23

TEF

WHO 2010

MethodRL

0.97 1

TEQ

0.20

EDL

ND = 0

1613B

Eurofins Pittsburgh

TEF Reference:

Project/Site: Newark NJ

Client Sample ID: #20230186 AMENDED COMPOSITE G (Continued)

Lab Sample ID: 180-153912-5

Analyte

1,2,3,7,8-PeCDD

Result

2.3

Qualifier

J q

Unit pg/g 2.3

TEF

WHO 2010

MethodRL

4.8 1

TEQ

0.84

EDL

ND = 0

1613B

1,2,3,4,7,8-HxCDD 3.2 J B pg/g 0.320.14.8 0.44 1613B

1,2,3,6,7,8-HxCDD 11 B pg/g 1.10.14.8 0.40 1613B

1,2,3,7,8,9-HxCDD 8.8 B pg/g 0.880.14.8 0.39 1613B

1,2,3,4,6,7,8-HpCDD 210 pg/g 2.10.014.8 0.15 1613B

OCDD 2300 B pg/g 0.690.00039.7 0.19 1613B

2,3,7,8-TCDF 11 pg/g 1.10.10.97 0.26 1613B

1,2,3,7,8-PeCDF 5.4 pg/g 0.160.034.8 0.22 1613B

2,3,4,7,8-PeCDF 9.0 pg/g 2.70.34.8 0.20 1613B

1,2,3,4,7,8-HxCDF 38 pg/g 3.80.14.8 0.24 1613B

1,2,3,6,7,8-HxCDF 12 I pg/g 1.20.14.8 0.27 1613B

2,3,4,6,7,8-HxCDF 5.3 B pg/g 0.530.14.8 0.25 1613B

1,2,3,7,8,9-HxCDF 0.63 J pg/g 0.0630.14.8 0.32 1613B

1,2,3,4,6,7,8-HpCDF 170 B pg/g 1.70.014.8 0.31 1613B

1,2,3,4,7,8,9-HpCDF 6.1 B pg/g 0.0610.014.8 0.35 1613B

OCDF 250 B pg/g 0.0750.00039.7 0.20 1613B

Analyte

Total Toxic Dioxins and Furans

Result Qualifier Unit pg/g 42

TEF

WHO 2010

MethodNONE TEQNONE

ND = 0

TEQ

Client Sample ID: #20230186 AMENDED COMPOSITE G Lab Sample ID: 180-153912-5

Prep Type: SPLP East

Analyte

2,3,7,8-TCDD

Result

9.5

Qualifier

U

Unit pg/L 0.00

TEF

WHO 2010

MethodRL

9.5 1

TEQ

0.94

EDL

ND = 0

1613B

1,2,3,7,8-PeCDD 47 U pg/L 0.00147 0.50 1613B

1,2,3,4,7,8-HxCDD 1.2 J B q pg/L 0.120.147 0.44 1613B

1,2,3,6,7,8-HxCDD 0.90 J B q pg/L 0.0900.147 0.41 1613B

1,2,3,7,8,9-HxCDD 0.76 J B pg/L 0.0760.147 0.39 1613B

1,2,3,4,6,7,8-HpCDD 47 U pg/L 0.000.0147 0.28 1613B

OCDD 2.6 J B q pg/L 0.000780.000395 0.31 1613B

2,3,7,8-TCDF 9.5 U pg/L 0.000.19.5 1.1 1613B

1,2,3,7,8-PeCDF 0.70 J B q pg/L 0.0210.0347 0.40 1613B

2,3,4,7,8-PeCDF 0.74 J q pg/L 0.220.347 0.37 1613B

1,2,3,4,7,8-HxCDF 47 U pg/L 0.000.147 0.73 1613B

1,2,3,6,7,8-HxCDF 47 U pg/L 0.000.147 0.77 1613B

2,3,4,6,7,8-HxCDF 47 U pg/L 0.000.147 0.78 1613B

1,2,3,7,8,9-HxCDF 47 U pg/L 0.000.147 0.97 1613B

1,2,3,4,6,7,8-HpCDF 0.65 J B q pg/L 0.00650.0147 0.20 1613B

1,2,3,4,7,8,9-HpCDF 0.77 J B q pg/L 0.00770.0147 0.25 1613B

OCDF 1.2 J B q pg/L 0.000360.000395 0.31 1613B

Eurofins Pittsburgh

TEF Reference:

Project/Site: Newark NJ

Client Sample ID: #20230186 AMENDED COMPOSITE G (Continued)

Lab Sample ID: 180-153912-5

Prep Type: SPLP East

Analyte

Total Toxic Dioxins and Furans

Result Qualifier Unit pg/L 0.54

TEF

WHO 2010

MethodNONE TEQNONE

ND = 0

TEQ

Client Sample ID: #20230192 AMENDED COMPOSITE M Lab Sample ID: 180-153912-6

Analyte

2,3,7,8-TCDD

Result

Qualifier

G

Unit pg/g 75

TEF

WHO 2010

MethodRL

1.3 1

TEQ

1.3

EDL

ND = 0

1613B

1,2,3,7,8-PeCDD 4.9 J pg/g 4.915.7 2.2 1613B

1,2,3,4,7,8-HxCDD 5.5 J B pg/g 0.550.15.7 1.9 1613B

1,2,3,6,7,8-HxCDD 23 B pg/g 2.30.15.7 1.8 1613B

1,2,3,7,8,9-HxCDD 17 B pg/g 1.70.15.7 1.7 1613B

1,2,3,4,6,7,8-HpCDD 450 pg/g 4.50.015.7 0.32 1613B

OCDD 4600 B pg/g 1.40.000311 0.23 1613B

2,3,7,8-TCDF 33 pg/g 3.30.11.1 0.69 1613B

1,2,3,7,8-PeCDF 14 pg/g 0.420.035.7 0.37 1613B

2,3,4,7,8-PeCDF 23 pg/g 6.90.35.7 0.35 1613B

1,2,3,4,7,8-HxCDF 78 I pg/g 7.80.15.7 0.39 1613B

1,2,3,6,7,8-HxCDF 26 pg/g 2.60.15.7 0.44 1613B

2,3,4,6,7,8-HxCDF 15 B pg/g 1.50.15.7 0.49 1613B

1,2,3,7,8,9-HxCDF 1.5 J pg/g 0.150.15.7 0.53 1613B

1,2,3,4,6,7,8-HpCDF 340 B pg/g 3.40.015.7 0.63 1613B

1,2,3,4,7,8,9-HpCDF 14 B pg/g 0.140.015.7 0.70 1613B

OCDF 510 B pg/g 0.150.000311 0.23 1613B

Analyte

Total Toxic Dioxins and Furans

Result Qualifier Unit pg/g 120

TEF

WHO 2010

MethodNONE TEQNONE

ND = 0

TEQ

Client Sample ID: #20230192 AMENDED COMPOSITE M Lab Sample ID: 180-153912-6

Prep Type: SPLP East

Analyte

2,3,7,8-TCDD

Result

9.9

Qualifier

U

Unit pg/L 0.00

TEF

WHO 2010

MethodRL

9.9 1

TEQ

0.70

EDL

ND = 0

1613B

1,2,3,7,8-PeCDD 49 U pg/L 0.00149 0.76 1613B

1,2,3,4,7,8-HxCDD 49 U pg/L 0.000.149 1.2 1613B

1,2,3,6,7,8-HxCDD 49 U pg/L 0.000.149 1.1 1613B

1,2,3,7,8,9-HxCDD 49 U pg/L 0.000.149 1.1 1613B

1,2,3,4,6,7,8-HpCDD 49 U pg/L 0.000.0149 1.1 1613B

OCDD 99 U pg/L 0.000.000399 3.3 1613B

2,3,7,8-TCDF 9.9 U pg/L 0.000.19.9 0.57 1613B

1,2,3,7,8-PeCDF 49 U pg/L 0.000.0349 0.27 1613B

Eurofins Pittsburgh

TEF Reference:

Project/Site: Newark NJ

Client Sample ID: #20230192 AMENDED COMPOSITE M (Continued)

Lab Sample ID: 180-153912-6

Prep Type: SPLP East

Analyte

2,3,4,7,8-PeCDF

Result

Qualifier

U

Unit pg/L 0.00

TEF

WHO 2010

MethodRL

49 0.3

TEQ

0.26

EDL

ND = 0

1613B

1,2,3,4,7,8-HxCDF 49 U pg/L 0.000.149 0.35 1613B

1,2,3,6,7,8-HxCDF 49 U pg/L 0.000.149 0.37 1613B

2,3,4,6,7,8-HxCDF 49 U pg/L 0.000.149 0.43 1613B

1,2,3,7,8,9-HxCDF 49 U pg/L 0.000.149 0.50 1613B

1,2,3,4,6,7,8-HpCDF 0.37 J q B pg/L 0.00370.0149 0.29 1613B

1,2,3,4,7,8,9-HpCDF 49 U pg/L 0.000.0149 0.35 1613B

OCDF 0.99 J B pg/L 0.000300.000399 0.24 1613B

Analyte

Total Toxic Dioxins and Furans

Result Qualifier Unit pg/L 0.0040

TEF

WHO 2010

MethodNONE TEQNONE

ND = 0

TEQ

Eurofins Pittsburgh

TEF Reference:

Default Detection Limits Client: Battelle Job ID: 180-153912-2 Project/Site: Newark NJ

Method: 1613B - Dioxins and Furans (HRGC/HRMS) Prep: HRMS-Sox

5.01,2,3,4,6,7,8-HpCDD pg/g

Analyte UnitsRL

5.01,2,3,4,6,7,8-HpCDF pg/g

5.01,2,3,4,7,8,9-HpCDF pg/g

5.01,2,3,4,7,8-HxCDD pg/g

5.01,2,3,4,7,8-HxCDF pg/g

5.01,2,3,6,7,8-HxCDD pg/g

5.01,2,3,6,7,8-HxCDF pg/g

5.01,2,3,7,8,9-HxCDD pg/g

5.01,2,3,7,8,9-HxCDF pg/g

5.01,2,3,7,8-PeCDD pg/g

5.01,2,3,7,8-PeCDF pg/g

5.02,3,4,6,7,8-HxCDF pg/g

5.02,3,4,7,8-PeCDF pg/g

1.02,3,7,8-TCDD pg/g

1.02,3,7,8-TCDF pg/g

10OCDD pg/g

10OCDF pg/g

Method: 1613B - Dioxins and Furans (HRGC/HRMS) - SPLP East Prep: HRMS-Sepf

501,2,3,4,6,7,8-HpCDD pg/L

Analyte UnitsRL

501,2,3,4,6,7,8-HpCDF pg/L

501,2,3,4,7,8,9-HpCDF pg/L

501,2,3,4,7,8-HxCDD pg/L

501,2,3,4,7,8-HxCDF pg/L

501,2,3,6,7,8-HxCDD pg/L

501,2,3,6,7,8-HxCDF pg/L

501,2,3,7,8,9-HxCDD pg/L

501,2,3,7,8,9-HxCDF pg/L

501,2,3,7,8-PeCDD pg/L

501,2,3,7,8-PeCDF pg/L

502,3,4,6,7,8-HxCDF pg/L

502,3,4,7,8-PeCDF pg/L

102,3,7,8-TCDD pg/L

102,3,7,8-TCDF pg/L

100OCDD pg/L

100OCDF pg/L

Surrogate Summary

Project/Site:…

This is the start of the file's text. The full file is on GovTribe.

File details come from the government source that posted it. Updated .